מדינה: אירלנד
שפה: אנגלית
מקור: HPRA (Health Products Regulatory Authority)
Triclabendazole, Ivermectin
Elanco Europe Ltd
QP54AA51
Triclabendazole, Ivermectin
50/1 milligram(s)/millilitre
Oral suspension
LM: Licensed Merchant as defined in relevant national legislation
Sheep
ivermectin, combinations
Endoparasiticide
Authorised
2016-06-17
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Fasimec Duo 50 mg/ml + 1 mg/ml oral suspension for sheep. 2 QUALITATIVE AND QUANTITATIVE COMPOSITION 3 PHARMACEUTICAL FORM Oral suspension Cream coloured aqueous oral suspension. 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES For sheep over 3 months of age. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES Treatment of mixed trematode (fluke) and nematode or arthropod infections due to gastrointestinal roundworms, lungworms, liver fluke and nasal bots. GASTROINTESTINAL NEMATODES (ADULT AND IMMATURE): _Haemonchus contortus, Teladorsagia (Ostertagia) circumcincta, Trichostrongylus spp, Cooperia spp, Nematodirus spp_ including_ N. battus_,_ Strongyloides papillosus, Oesophagostomum spp_, and adult_ Chabertia ovina._ Inhibited larval stages and benzimidazole resistant strains of_ Haemonchus contortus_ and_ Teladorsagia (Ostertagia)_ _circumcincta_ are also controlled. LIVER FLUKE (MATURE, IMMATURE AND EARLY IMMATURE STAGES DOWN TO LESS THAN 1 WEEK OF AGE): _Fasciola hepatica_ LUNGWORMS (ADULT AND IMMATURE): _Dictyocaulus filaria_ NASAL BOTS (ALL STAGES): _Oestrus ovis_ 4.3 CONTRAINDICATIONS Do not use in animals with known hypersensitivity to the active ingredients or any of the excipients. ACTIVE INGREDIENTS: Ivermectin 1 mg/ml Triclabendazole 50 mg/ml EXCIPIENTS: Methyl parahydroxybenzoate (E218) 1.4 mg/ml Propyl parahydroxybenzoate (E216) 0.5 mg/ml Benzyl alcohol 5.0 mg/ml For a full list of excipients, see section 6.1. H E A L T H P R O D U C T S R E G U L A T O R Y A U T H O R I T Y ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ _ קרא את המסמך השלם